Compare
Specificity, Inc. vs Kidoz Inc. vs Haoxi Health Technology Ltd vs Stran & Company, Inc.
| Latest fiscal year | Specificity, Inc. SPTY | Kidoz Inc. KDOZF | Haoxi Health Technology Ltd HAO | Stran & Company, Inc. SWAG |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-12-31 |
| Revenue | $1.09M | $18.43M | $54.83M | $116.19M |
| Revenue growth (YoY) | +10.0% | +31.6% | +67.1% | +40.6% |
| Gross margin | 40.4% | 48.4% | 1.1% | 29.5% |
| Operating margin | -34.0% | 2.3% | -17.6% | -1.7% |
| Net margin | -50.8% | 2.5% | -17.4% | -0.6% |
| Net income | -$554.1K | $456.8K | -$9.54M | -$747.0K |
| EPS (Diluted) | -$0.04 | $0.00 | -$386.40 | -$0.04 |
| Operating cash flow | -$149.4K | $1.71M | -$2.57M | -$4.67M |
| Free cash flow | n/a | $1.68M | n/a | -$5.50M |
| Cash & equivalents | $2.0K | $4.46M | $10.93M | $6.75M |
| Total assets | $1.56M | $13.17M | $21.57M | $49.35M |
| Total liabilities | $2.26M | $4.54M | $3.71M | $18.85M |
| Shareholders' equity | -$709.2K | $8.64M | $17.86M | $30.50M |
| Return on year-end equity | n/a | 5.3% | -53.4% | -2.4% |
| Shares outstanding | 15.31M | 131.30M | n/a | 18.51M |
Revenue, most recent five fiscal years
| Fiscal year | Specificity, Inc. | Kidoz Inc. | Haoxi Health Technology Ltd | Stran & Company, Inc. |
|---|---|---|---|---|
| Latest | $1.09M Ended 2025-12-31 | $18.43M Ended 2025-12-31 | $54.83M Ended 2026-06-30 | $116.19M Ended 2025-12-31 |
| 1 year earlier | $991.1K Ended 2024-12-31 | $14.00M Ended 2024-12-31 | $32.80M Ended 2025-06-30 | $82.65M Ended 2024-12-31 |
| 2 years earlier | $1.10M Ended 2023-12-31 | $13.33M Ended 2023-12-31 | $48.52M Ended 2024-06-30 | $76.00M Ended 2023-12-31 |
| 3 years earlier | $1.18M Ended 2022-12-31 | $15.10M Ended 2022-12-31 | $28.23M Ended 2023-06-30 | $57.88M Ended 2022-12-31 |
| 4 years earlier | $749.0K Ended 2021-12-31 | $12.48M Ended 2021-12-31 | $16.16M Ended 2022-06-30 | $39.70M Ended 2021-12-31 |